Journal for ImmunoTherapy of Cancer (Nov 2023)
1515 Gene edited iPSC-derived macrophages (iMACs) show increased phagocytosis in pre-clinical tumor models
- Daniel Sommermeyer,
- Monika Braun,
- Michael Epstein,
- Tanja Schneider,
- Kathrin Haake,
- Michela Mirenda,
- Quentin Bernard,
- Philip Hublitz,
- Lucie Gouxette,
- Martin Briscadieu,
- Philine Scheinpflug,
- Garima Singh,
- Alica Hinkelmann,
- Michael Esquerré,
- Audrey Holtzinger,
- Michael Paillasse,
- Andreas Scheel,
- Markus Dangl,
- Nadja Wagner
Affiliations
- Daniel Sommermeyer
- 1Evotec International GmbH, Goettingen, Germany
- Monika Braun
- 1Evotec International GmbH, Goettingen, Germany
- Michael Epstein
- 3Evotec (UK) Ltd, Abingdon, UK
- Tanja Schneider
- 1Evotec International GmbH, Goettingen, Germany
- Kathrin Haake
- 1Evotec International GmbH, Goettingen, Germany
- Michela Mirenda
- 2Evotec France SAS, Toulouse, France
- Quentin Bernard
- 2Evotec France SAS, Toulouse, France
- Philip Hublitz
- 1Evotec International GmbH, Goettingen, Germany
- Lucie Gouxette
- 2Evotec France SAS, Toulouse, France
- Martin Briscadieu
- 2Evotec France SAS, Toulouse, France
- Philine Scheinpflug
- 1Evotec International GmbH, Goettingen, Germany
- Garima Singh
- 1Evotec International GmbH, Goettingen, Germany
- Alica Hinkelmann
- 1Evotec International GmbH, Goettingen, Germany
- Michael Esquerré
- 2Evotec France SAS, Toulouse, France
- Audrey Holtzinger
- 1Evotec International GmbH, Goettingen, Germany
- Michael Paillasse
- 2Evotec France SAS, Toulouse, France
- Andreas Scheel
- 1Evotec International GmbH, Goettingen, Germany
- Markus Dangl
- 1Evotec International GmbH, Goettingen, Germany
- Nadja Wagner
- 4Evotec, Hamburg, Germany
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1515
- Journal volume & issue
-
Vol. 11,
no. Suppl 2
Abstract
No abstracts available.
